A Case of Locally Advanced Castration-resistant Prostate Cancer With Remarkable Response to Nivolumab

Clin Genitourin Cancer. 2017 Oct;15(5):e881-e884. doi: 10.1016/j.clgc.2017.05.005. Epub 2017 May 24.

Authors

Alina Basnet¹, Gaurav Khullar², Rohin Mehta², Namita Chittoria³

Affiliations

¹ Department of Hematology/Oncology, SUNY Upstate Medical University, Syracuse, NY. Electronic address: basneta@upstate.edu.
² Department of Pathology, SUNY Upstate Medical University, Syracuse, NY.
³ VA Medical Center, Syracuse, NY.

PMID: 28625691
DOI: 10.1016/j.clgc.2017.05.005

No abstract available

Keywords: Androgen deprivation therapy; Castrate resistant; Immunotherapy; Nivolumab; Prostate cancer.

Publication types

Case Reports

MeSH terms

Aged
Antibodies, Monoclonal / therapeutic use*
Antineoplastic Agents / therapeutic use*
Humans
Immunotherapy
Male
Nivolumab
Prostatic Neoplasms, Castration-Resistant / diagnostic imaging
Prostatic Neoplasms, Castration-Resistant / drug therapy*
Tomography, X-Ray Computed
Treatment Outcome

Substances

Antibodies, Monoclonal
Antineoplastic Agents
Nivolumab